Internal Medicine, Hematology & Oncology · Chattanooga, TN
NPI
1306068135
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1032 McCallie Ave Ste 200
Chattanooga, TN, 37403
Phone (423) 752-5004
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.0M
139,885 services
Medicare patients, 2024
812
Average age 74
Drug cost, 2024
$8.1M
3,168 prescriptions
Company payments, 2025
$297
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert M Graham was code J9271 (injection, pembrolizumab, 1 mg), 14,000 times for 16 patients. In total Robert M Graham billed 139,885 services in 192 codes, and Medicare paid $4.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 14,000 | 16 | $44.40 | $622K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 6,150 | 57 | $0.10 | $644 |
| J1453 Injection, fosaprepitant, 1 mg | Office | 6,000 | 13 | $0.11 | $662 |
| J0897 Injection, denosumab, 1 mg | Office | 2,280 | 12 | $20.41 | $47K |
| 85025 Blood Count | Office | 2,109 | 427 | $7.56 | $16K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 1,900 | 18 | $14.83 | $28K |
| 36415 Venipuncture Blood Collection | Office | 1,780 | 387 | $8.60 | $15K |
| 80053 Clinical Chemistry | Office | 1,767 | 373 | $10.30 | $18K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,304 | 38 | $0.09 | $116 |
| 99215 Office E&M - Established | Office | 813 | 199 | $124.63 | $101K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 740 | 21 | $0.25 | $187 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 542 | 305 | $12.04 | $6,523 |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 528 | 11 | $3.29 | $1,739 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 490 | 15 | $0.66 | $324 |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 490 | 77 | $71.24 | $35K |
By year: 2022 $2.2M for 118,810 services; 2023 $3.6M for 171,945 services; 2024 $4.0M for 139,885 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,109 | 427 | $7.56 | $16K |
| 36415 Venipuncture Blood Collection | 1,780 | 387 | $8.60 | $15K |
| 80053 Clinical Chemistry | 1,767 | 373 | $10.30 | $18K |
| 82784 Immunoassay | 445 | 43 | $9.08 | $4,039 |
| 83521 Immunoassay | 288 | 42 | $16.84 | $4,851 |
| 84443 Clinical Chemistry | 272 | 75 | $16.46 | $4,477 |
| 84153 Clinical Chemistry | 271 | 64 | $18.02 | $4,883 |
| 84439 Clinical Chemistry | 237 | 58 | $8.84 | $2,095 |
| 82533 Clinical Chemistry | 156 | 37 | $15.97 | $2,491 |
| 84165 Clinical Chemistry | 149 | 44 | $10.49 | $1,563 |
Medicare prescription drug claims, 2024
In 2024, the drug Robert M Graham prescribed most often to Medicare patients was Abiraterone Acetate, with 372 prescriptions and refills. In total Robert M Graham wrote 3,168 Medicare prescriptions that cost $8.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Abiraterone Acetate Generic | 372 | 372 | 41 | $640K |
| Prednisone Generic | 338 | 361 | 54 | $1,092 |
| Anastrozole Generic | 102 | 234 | 34 | $1,869 |
| Ondansetron Odt Ondansetron | 98 | 98 | 49 | $2,375 |
| Prochlorperazine Maleate Generic | 93 | 93 | 51 | $1,466 |
| Eliquis Apixaban | 89 | 121 | 22 | $71K |
| Acyclovir Generic | 78 | 88 | 13 | $552 |
| Dexamethasone Generic | 71 | 86 | 30 | $1,065 |
| Xtandi Enzalutamide | 69 | 69 | Under 11 | $759K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 58 | 83 | 30 | $228 |
| Levothyroxine Sodium Generic | 56 | 96 | 21 | $282 |
| Buspirone Hcl Generic | 53 | 62 | 18 | $475 |
| Calquence Acalabrutinib Maleate | 52 | 52 | Under 11 | $606K |
| Ondansetron Hcl Generic | 51 | 56 | 23 | $755 |
| Revlimid Lenalidomide | 48 | 48 | Under 11 | $695K |
Brand drugs: 736 claims; generic drugs: 2,432 claims; opioid claims: 108.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert M Graham $297 ($297 in general payments such as food, travel and fees) from 12 companies. The largest payer was Novartis Pharmaceuticals Corporation with $49.37.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 2 | $49.37 |
| Janssen Biotech, Inc. JNJ | 1 | $49.28 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $26.8 |
| Gilead Sciences, Inc. GILD | 1 | $26.32 |
| GlaxoSmithKline, LLC. GSK | 1 | $25.66 |
| Lilly USA, LLC LLY | 1 | $22.19 |
| Genzyme Corporation SNY | 1 | $20.44 |
| Aveo Pharmaceuticals, Inc. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $19.83 |
| Astellas Pharma US Inc 4503.T | 1 | $19.49 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.